Milaan, Italy

Maria Grazia De Simoni


 

Average Co-Inventor Count = 5.0

ph-index = 2

Forward Citations = 49(Granted Patents)


Company Filing History:


Years Active: 2011-2015

Loading Chart...
Loading Chart...
3 patents (USPTO):Explore Patents

Title: Maria Grazia De Simoni: Innovator in Ischemia-Reperfusion Injury Treatment

Introduction

Maria Grazia De Simoni is a prominent inventor based in Milan, Italy. She has made significant contributions to the field of medicine, particularly in the treatment of ischemia-reperfusion injury. With a total of three patents to her name, her work is recognized for its therapeutic potential.

Latest Patents

One of her latest patents focuses on the use of C1 inhibitor for the prevention of ischemia-reperfusion injury. This invention relates to the therapeutic and prophylactic use of C1 inhibitor for preventing, reducing, and treating ischemia and reperfusion injury. The C1 inhibitor is particularly effective when administered after an ischemic period and reperfusion, making it useful for unforeseen occurrences such as strokes.

Career Highlights

Maria Grazia De Simoni has established herself as a key figure in her field. Her innovative approaches to medical treatment have garnered attention and respect from her peers. She is currently associated with Pharming Intellectual Property Bv, where she continues to advance her research and development efforts.

Collaborations

Throughout her career, Maria has collaborated with notable colleagues, including Maurice Mannesse and Johannes Henricus Nuijens. These partnerships have contributed to the success of her projects and the advancement of medical science.

Conclusion

Maria Grazia De Simoni is a trailblazer in the field of ischemia-reperfusion injury treatment. Her innovative patents and collaborations highlight her commitment to improving patient outcomes. Her work continues to inspire future advancements in medical research.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…